The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
We expect the global intraocular lens market to exhibit a CAGR of 5.53% during 2022-2027.
The rising prevalence of cataract particularly among the geriatric population, along with the introduction of trifocal lenses that eliminate the need for spectacles, is primarily catalyzing the global intraocular lens market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of numerous elective vision correction surgeries to combat the risk of coronavirus infection upon hospital/clinic visits.
Based on the product, the global intraocular lens market can be segmented into monofocal IOL, multifocal IOL, toric IOL, and accommodative IOL. Currently, multifocal IOL holds the majority of the total market share.
Based on the material, the global intraocular lens market has been divided into polymethylmethacrylate (PMMA), silicone, and hydrophobic acrylic, where hydrophobic acrylic currently exhibits a clear dominance in the market.
Based on the end use, the global intraocular lens market can be categorized into hospitals, ophthalmic clinics, ambulatory care centers, and eye research institutes. Among these, hospitals account for the majority of the global market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global intraocular lens market include Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG (Carl-Zeiss-Stiftung), EyeKon Medical Inc., Hoya Corporation, HumanOptics AG, Johnson & Johnson, Lenstec Inc., Rayner Intraocular Lenses Limited, and STAAR Surgical Company.
Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at